News Search

Topics

View All Topics

Showing 211 - 220 of 392 results.

What's Better for Your Brain, Crossword Puzzles or Computer Games?

By Amy Norton

November 2, 2022

"This is not definitive," said lead researcher Dr. Davangere Devanand, a professor of psychiatry and neurology at CUIMC. He said that larger studies, including a control group, are still needed

Topic

Dementia
Meet Dr. Robert J. Wechsler-Reya

October 28, 2022

Please join in welcoming Dr. Robert J. Wechsler-Reya to the department.

Topic

Research
One in 10 Older Americans Has Dementia

October 26, 2022

A new study, lead by Dr. Jennifer J. Manly, shows that 1 in 10 Americans age 65 and over suffer from dementia, while 22% deal with mild cognitive impairment.

Topic

Dementia
Some People Who Appear to Be in a Coma May Actually Be Conscious

By Jan Claassen and Brian L. Edlow

October 18, 2022

With covert consciousness, the lack of outward movement is complete, even more so than with locked-in patients. But this does not mean the absence of inner life.

Topic

Critical Care Neurology
Why You Should Think Acute Flaccid Myelitis, Not Just Polio The Signs and Symptoms to Look for

By Susan Fitzgerald

October 6, 2022

Despite a recent case of paralytic polio in New York state and evidence of community transmission of the virus, experts point out that other causes could be behind patients' symptoms.

Topic

Neuroinfectious Diseases
Columbia Scientists Receive Prestigious New Innovator Awards from NIH

October 4, 2022

Christopher Makinson, PhD, assistant professor of neurological sciences, was among 4 Columbia University members to received “New Innovator” awards from the NIH’s High-Risk, High-Reward program

Topic

Awards and Accomplishments
FDA Approves First ALS Drug in 5 Years After Pleas From Patients

By Laurie McGinley

September 29, 2022

The Food and Drug Administration on Thursday overcame doubts from agency scientists and approved a fiercely debated drug for ALS

Topic

ALS
Special Notice: New AD Treatment Lecanemab

September 28, 2022

A landmark study has shown lecanemab treatment to slow the course of Alzheimer’s disease. Lecanemab is now under consideration by the FDA but is not yet approved or available commercially.
Alzheimer Drug Trial Results Change 'Landscape'

September 28, 2022

Dr. Lawrence Honig, professor of neurology at Columbia University Irving Medical Center, speaks about the new Alzheimer drug trial results

Topic

Alzheimer's Disease
In Memoriam: Blair Ford, MD

September 27, 2022

With great sadness and regret, we share news of the death of our esteemed colleague, Blair Ford, MD.

Topic

In Memorium

News Search

Topics

Topic

Topic

Topic

Topic

Topic

Topic

Topic

Topic

Topic

Pages